Clinical trial
Comparison of Intramuscular Olanzapine Depot to Oral Olanzapine and Low-Dose…
NCT00088491 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT00088491 |
|---|---|
| Title | Comparison of Intramuscular Olanzapine Depot to Oral Olanzapine and Low-Dose Depot in Patients With Schizophrenia |
| Official title | A Double-Blind, Randomized Study Comparing Intramuscular Olanzapine Depot to Oral Olanzapine and Low-Dose Depot in the Maintenance Therapy of Patients With Schizophrenia |
| Lead sponsor | Eli Lilly and Company, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Schizophrenic Disorders |
| Intervention type | Drug |
| Interventions | Intramuscular Olanzapine Depot, Oral Olanzapine |
| Enrollment | 1,205 |
| Start date | Jun 1, 2004 |
| Completion | Oct 1, 2006 |
| First posted | Jul 28, 2004 |
| Last update posted | Jun 22, 2007 |
| Countries | Finland, Turkey (Türkiye) |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: